Extended‐Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction
Background Heart failure with preserved ejection fraction (HFpEF) is an increasingly prevalent form of heart failure, representing half of the total burden of heart failure. We hypothesised that modulation of the phosphodiesterase type 3/cyclic AMP using a novel oral formulation of milrinone might e...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley
2020-07-01
|
| Saila: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.ahajournals.org/doi/10.1161/JAHA.119.015026 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|